Glaukos recently obtained FDA clearance for Epioxa, a topical, incision-free therapy for keratoconus that preserves the ...

At the government-run Minto Ophthalmic Hospital, 37 cases were reported, including 14 grievous ones. Two patients suffered ...

A phase 2 study supports the use of a microRNA eye drop for patients with corneal damage or dry eye disease.

Epioxa does not require the removal of the corneal epithelium, a step usually required by traditional corneal cross-linking procedures, thereby minimizing pain and recovery time.